We are hopeful that anti-TNF therapy, first identified by Professor Sir Marc Feldmann and the Trust’s President Professor Sir Ravinder Maini, might prove to be an effective treatment for patients with COVID-19.
We are hopeful that anti-TNF therapy, first identified by Professor Sir Marc Feldmann and the Trust’s President Professor Sir Ravinder Maini, might prove to be an effective treatment for patients with COVID-19.
